Beam Therapeutics SVP sells 187 shares for tax withholding
Alpha Vantage · Kalkine Media · · AI-summarised by FinFlash
Beam Therapeutics SVP, Finance and Treasurer Bethany J. Cavanagh sold 187 shares of common stock at $24.41 per share on October 1, 2026, according to a filing. The sale was a non-discretionary transaction executed under a Rule 10b5-1 trading plan to cover tax withholding obligations tied to vesting restricted stock units. Cavanagh directly holds 50,984 shares following the transaction.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.